Does EVEROLIMUS Cause Aplastic anaemia? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Aplastic anaemia have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.0% of all adverse event reports for EVEROLIMUS.
13
Reports of Aplastic anaemia with EVEROLIMUS
0.0%
of all EVEROLIMUS reports
10
Deaths
13
Hospitalizations
How Dangerous Is Aplastic anaemia From EVEROLIMUS?
Of the 13 reports, 10 (76.9%) resulted in death, 13 (100.0%) required hospitalization, and 9 (69.2%) were considered life-threatening.
Is Aplastic anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Aplastic anaemia?
ECULIZUMAB (345)
CYCLOPHOSPHAMIDE (332)
CYCLOSPORINE (331)
METHOTREXATE (281)
BUSULFAN (220)
FLUDARABINE (220)
ETOPOSIDE (186)
VINCRISTINE (173)
CYTARABINE (163)
ELTROMBOPAG OLAMINE (149)
Which EVEROLIMUS Alternatives Have Lower Aplastic anaemia Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE